Are Investors Undervaluing Aperam (APEMY) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.
Considering these trends, value investing is clearly one of the most preferred ways to find strong stocks in any type of market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels.
On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.
One company to watch right now is Aperam (APEMY). APEMY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 9.23, which compares to its industry's average of 10.11. Over the past year, APEMY's Forward P/E has been as high as 12.82 and as low as 6.80, with a median of 9.57.
We should also highlight that APEMY has a P/B ratio of 0.80. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. This stock's P/B looks attractive against its industry's average P/B of 1.04. APEMY's P/B has been as high as 1.43 and as low as 0.67, with a median of 0.92, over the past year.
Value investors will likely look at more than just these metrics, but the above data helps show that Aperam is likely undervalued currently. And when considering the strength of its earnings outlook, APEMY sticks out at as one of the market's strongest value stocks.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Aperam (APEMY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
